Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000870367 | SCV001011861 | likely benign | Fanconi anemia | 2024-07-31 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV004973097 | SCV005583246 | likely benign | Inborn genetic diseases | 2024-11-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Natera, |
RCV001276554 | SCV001462952 | uncertain significance | Fanconi anemia complementation group A | 2020-01-24 | no assertion criteria provided | clinical testing | |
| Prevention |
RCV004742666 | SCV005344271 | likely benign | FANCA-related disorder | 2024-06-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |